Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactulose for Primary Prophylaxis of Hepatic Encephalopathy in Cirrhosis
NCT01175538Phase 4Unknown
- Sponsor
- Govind Ballabh Pant Hospital
- Start
- Jan 2008
- Primary completion
- Jun 2010
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of lactulose in hepatic encephalopathy (HE) (2 arms), sponsored by Govind Ballabh Pant Hospital. Primary endpoint: Prevention of first episode of hepatic encephalopathy at 6 months. Status: unknown.
02
Drugs
lactulose
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT01175538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01175538.